JP2007513873A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513873A5 JP2007513873A5 JP2006536183A JP2006536183A JP2007513873A5 JP 2007513873 A5 JP2007513873 A5 JP 2007513873A5 JP 2006536183 A JP2006536183 A JP 2006536183A JP 2006536183 A JP2006536183 A JP 2006536183A JP 2007513873 A5 JP2007513873 A5 JP 2007513873A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- agent
- antibody
- expression
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0324656A GB0324656D0 (en) | 2003-10-22 | 2003-10-22 | A protein involved in ovarian cancer |
| GB0324656.8 | 2003-10-22 | ||
| PCT/GB2004/004502 WO2005042102A1 (en) | 2003-10-22 | 2004-10-22 | A protein involved in ovarian cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007513873A JP2007513873A (ja) | 2007-05-31 |
| JP2007513873A5 true JP2007513873A5 (enExample) | 2007-10-18 |
| JP4764344B2 JP4764344B2 (ja) | 2011-08-31 |
Family
ID=29595617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006536183A Expired - Fee Related JP4764344B2 (ja) | 2003-10-22 | 2004-10-22 | 卵巣癌に関与するタンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20070009543A1 (enExample) |
| EP (1) | EP1677875B1 (enExample) |
| JP (1) | JP4764344B2 (enExample) |
| AT (1) | ATE470478T1 (enExample) |
| AU (1) | AU2004285339B2 (enExample) |
| CA (1) | CA2541846A1 (enExample) |
| DE (1) | DE602004027647D1 (enExample) |
| ES (1) | ES2347249T3 (enExample) |
| GB (1) | GB0324656D0 (enExample) |
| PL (1) | PL1677875T3 (enExample) |
| WO (1) | WO2005042102A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080008719A1 (en) * | 2004-07-10 | 2008-01-10 | Bowdish Katherine S | Methods and compositions for the treatment of prostate cancer |
| WO2007089513A2 (en) * | 2006-01-26 | 2007-08-09 | The Trustees Of The University Of Pennsylvania | Tumor vasculature markers and methods of use thereof |
| US20130136689A1 (en) * | 2007-06-05 | 2013-05-30 | Christian Rohlff | Proteins |
| WO2009006439A1 (en) | 2007-06-29 | 2009-01-08 | Correlogic Systems, Inc. | Predictive markers for ovarian cancer |
| TWI412375B (zh) | 2009-08-28 | 2013-10-21 | Roche Glycart Ag | 人類化抗ｃｄｃｐ１抗體 |
| TW201113037A (en) | 2009-08-28 | 2011-04-16 | Hoffmann La Roche | Antibodies against CDCP1 for the treatment of cancer |
| ES2689668T3 (es) | 2013-03-13 | 2018-11-15 | Nantenergy, Inc. | Aditivos sinérgicos para celdas electroquímicas con combustible electrodepositado |
| WO2015082446A1 (en) | 2013-12-02 | 2015-06-11 | F. Hoffmann-La Roche Ag | Treatment of cancer using an anti-cdcp1 antibody and a taxane |
| EP3554544A4 (en) | 2016-12-16 | 2020-07-29 | Bluefin Biomedicine, Inc. | ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE |
| US11424484B2 (en) | 2019-01-24 | 2022-08-23 | Octet Scientific, Inc. | Zinc battery electrolyte additive |
| WO2021087575A1 (en) * | 2019-11-06 | 2021-05-14 | Commonwealth Scientific And Industrial Research Organisation | Binding proteins to cub domain-containing protein (cdcp1) |
| CN118440203A (zh) | 2019-12-27 | 2024-08-06 | 凯奥目生物科学株式会社 | 抗cdcp1抗体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1100869A4 (en) | 1998-07-30 | 2005-04-27 | Human Genome Sciences Inc | 98 HUMAN SECRETED PROTEINS |
| US7442776B2 (en) * | 1999-10-08 | 2008-10-28 | Young David S F | Cancerous disease modifying antibodies |
| EP1301533A1 (de) | 2000-07-07 | 2003-04-16 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Tumorassoziiertes antigen (b345), gekennzeichnet durch eine aminosäuresequenz wie in seq. id. no. 4 |
| US20020142003A1 (en) * | 2000-07-07 | 2002-10-03 | Norbert Schweifer | Tumor-associated antigen (B345) |
| US6783969B1 (en) | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
| BRPI0407680A (pt) | 2003-02-19 | 2006-03-01 | Novartis Ag | métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas |
-
2003
- 2003-10-22 GB GB0324656A patent/GB0324656D0/en not_active Ceased
-
2004
- 2004-10-22 PL PL04769011T patent/PL1677875T3/pl unknown
- 2004-10-22 ES ES04769011T patent/ES2347249T3/es not_active Expired - Lifetime
- 2004-10-22 DE DE200460027647 patent/DE602004027647D1/de not_active Expired - Lifetime
- 2004-10-22 WO PCT/GB2004/004502 patent/WO2005042102A1/en not_active Ceased
- 2004-10-22 JP JP2006536183A patent/JP4764344B2/ja not_active Expired - Fee Related
- 2004-10-22 EP EP20040769011 patent/EP1677875B1/en not_active Revoked
- 2004-10-22 AU AU2004285339A patent/AU2004285339B2/en not_active Ceased
- 2004-10-22 US US10/575,311 patent/US20070009543A1/en not_active Abandoned
- 2004-10-22 CA CA 2541846 patent/CA2541846A1/en not_active Abandoned
- 2004-10-22 AT AT04769011T patent/ATE470478T1/de active
-
2009
- 2009-10-14 US US12/587,870 patent/US8263071B2/en not_active Expired - Fee Related
-
2012
- 2012-08-03 US US13/566,011 patent/US9120860B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7022969B2 (ja) | ＳＡＲＳ－ＣｏＶ－２感染症を診断するための方法および試薬 | |
| JP6100822B2 (ja) | プロカルシトニンの検出のためのイムノアッセイ | |
| EP2828282B1 (en) | Biomarkers | |
| RS53270B2 (sr) | Monoklonalna antitela protiv amiloidnog beta proteina i njihova upotreba | |
| JP2014506244A5 (enExample) | ||
| JP2012515226A5 (enExample) | ||
| JP2009544284A5 (enExample) | ||
| Okochi et al. | Array-based rational design of short peptide probe-derived from an anti-TNT monoclonal antibody | |
| CA2239208A1 (en) | Treatment and diagnosis of infections due to helicobacter pylori | |
| JP2011501946A5 (enExample) | ||
| Lévêque et al. | Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism | |
| US7842456B2 (en) | Reagents, kits and methods for immunodetection of epitopes on molecules | |
| EP2332988A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| JP2005522228A5 (enExample) | ||
| EP3227681B1 (en) | Anti-acetaminophen antibodies and acetaminophen protein adducts | |
| JP2021528411A5 (enExample) | ||
| Snitkoff et al. | Development of an immunoassay for monitoring the levels of ciprofloxacin patient samples | |
| JP2012503634A5 (enExample) | ||
| JP2008509082A5 (enExample) | ||
| JPWO2024090571A5 (enExample) | ||
| JP2005522229A5 (enExample) | ||
| Morrissey et al. | Kinetics of antigen− antibody interactions employing a MALDI mass spectrometry immunoassay | |
| CA2771954A1 (en) | Pneumonia biomarkers | |
| US10094833B2 (en) | Method and kit for detecting bacterial infection | |
| JP2008512391A5 (enExample) |